NTrans Technologies
PrivateLast Round
Series A
Jun 1, 2021
Total Funding Raised
$2.44M
Company Overview
NTrans Technologies operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Series A round in June 2021.
NTrans Technologies is a biotechnology company that develops a proprietary non-viral delivery platform for the intracellular delivery of gene-editing complexes and other bioactive molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NTrans Technologies Comparables
Compare NTrans Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indee Labs | 85% | |
| Kytopen | 84% | |
| Avectas | 82% |
For institutional investors. Book with your work email.
NTrans Technologies Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NTrans Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Starfish Innovations | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2025
Monthly visitors increased 1130% MoM, reaching 738.
- Jun 1, 2021
$2.44M round led by Starfish Innovations and uhsf-nl.
For institutional investors. Book with your work email.
NTrans Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NTrans Technologies's valuation, stock price, and market status.
Is NTrans Technologies a public or private company?
NTrans Technologies is a private company.
What is the current stock price of NTrans Technologies?
NTrans Technologies is a private company, so its shares have no public market price. Caplight tracks NTrans Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NTrans Technologies worth (valuation)?
Valuation information for NTrans Technologies is not publicly available.
Can I buy NTrans Technologies stock?
NTrans Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NTrans Technologies's last funding round?
NTrans Technologies's most recent funding round was Series A on June 1, 2021.
Who are the main investors in NTrans Technologies?
Key investors in NTrans Technologies include Starfish Innovations.
Will NTrans Technologies IPO soon?
No public IPO plans have been announced for NTrans Technologies.
How can I track NTrans Technologies secondary market activity?
Caplight tracks bids, offers, and trades in NTrans Technologies's shares on secondary markets.